NRP1 and COVID-19: With the direct activation of AP-1 (c-Jun and c-Fos) in NRP1–CTSL pairs, monocyte/macrophage cells may be more susceptible to SARS-CoV-2 infection in COVID-19 patients compared to healthy donors.